Japan Coronary Stents Market Insights Forecasts to 2033
- The Japan Coronary Stents Market Size was valued at USD 708.11 Million in 2023.
- The Market Size is Growing at a CAGR of 5.0% from 2023 to 2033.
- The Japan Coronary Stents Market Size is Expected to Reach USD 1155.32 Million by 2033.
Get more details on this report -
The Japan Coronary Stents Market Size is Expected to Reach USD 1155.32 Million by 2033, at a CAGR of 5.0% during the forecast period 2023 to 2033.
Coronary stents are life-saving medical devices that are used to treat coronary artery disease (CAD), a common condition in which plaque accumulates inside the arteries, reducing blood flow to the heart. These small, mesh-like tubes, which are typically made of metal or biodegradable materials, are inserted into narrowed or blocked coronary arteries during an angioplasty procedure. Coronary stents are extremely important in restoring blood flow to the heart muscle. They function by expanding within the narrowed artery, effectively pushing aside the plaque and allowing blood to flow freely. This procedure not only alleviates symptoms such as chest pain, but it also aids in the prevention of heart attacks and other cardiac complications. Coronary stents are classified into two types that are bare-metal stents and drug-eluting stents. While bare-metal stents are simple and effective, drug-eluting stents are coated with medications that gradually release over time, lowering the risk of artery re-narrowing. Stent technology advancements in recent years have improved their safety and effectiveness, making them an essential tool in the management of CAD.
This research report categorizes the market for Japan Coronary Stents market based on various segments and regions and forecasts revenue growth and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the Japan Coronary Stents market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segments of the Japan Coronary Stents market.
Japan Coronary Stents Market Report Coverage
|Market Size in 2023:
|USD 708.11 Million
|2023 - 2033
|Forecast Period 2023 - 2033 CAGR:
|2033 Value Projection:
|USD 1155.32 Million
|Historical Data for:
|2019 - 2022
|No. of Pages:
|Tables, Charts & Figures:
|By Type, By Deployment and COVID-19 Impact Analysis.
|Terumo Corporation, Fukuda, B. Braun Melsungen, Abbott Laboratories, Biotronik SE & Co, Medtronic, GE Healthcare, Boston Scientific, Philips Healthcare, Lepu Medical Technology, Meril Life Sciences, MicroPort Scientific, Sahajanand Medical Technologies, Translumina Therapeutics, Vascular Concepts, and Others
|Pitfalls & Challenges:
|COVID-19 Empact, Challenge, Future, Growth, & Analysis
Get more details on this report -
Several key factors drive the Japanese coronary stents market. The rising prevalence of cardiovascular diseases such as CAD has increased the demand for coronary stents. Furthermore, the aging regional population is a significant driver, as the elderly are more vulnerable to these ailments. Furthermore, advances in medical technology and the development of novel stent designs have resulted in improved treatment outcomes, fueling market growth. Furthermore, increasing patient awareness of the benefits of minimally invasive procedures, as well as their preference for them, has boosted the use of coronary stents. Furthermore, in Japan, favorable reimbursement policies have encouraged both patients and healthcare providers to choose stent implantation procedures. Aside from that, rising healthcare costs, combined with rising disposable income, have all contributed to the growth of the coronary stents market. Furthermore, ongoing R&D efforts by pharmaceutical and medical device companies to develop more efficient and durable stents are expected to drive the Japanese coronary stents market during the forecast period.
The growing demand for treatment options and the side effects associated with coronary stent use may limit growth to some extent. Furthermore, stringent government regulations governing product approval will limit market growth. As a result, the aforementioned factors are the primary reasons limiting growth.
- In 2023, the drug-eluting stents segment accounted for the largest revenue share over the forecast period.
Based on the type, the Japan coronary stents market is segmented into drug-eluting stents, bare-metal coronary stents, and bioabsorbable stents. Among these, the drug-eluting stents segment has the largest revenue share over the forecast period. It is primarily due to the increasing popularity and demand for these stents due to their medicine-coated layer on the metal that aids in reopening and maintaining the artery. Furthermore, with the rising prevalence of coronary diseases among the aging and obese population, demand for these stents is rapidly increasing, contributing to Japan market growth.
- In 2022, the self-expandable segment accounted for the largest revenue share over the forecast period.
Based on the deployment, the Japan coronary stents market is segmented into self-expandable, and balloon-expandable. Among these, the self-expandable segment has the largest revenue share over the forecast period. Due to the rising awareness among patients about the clinically proven efficiency of these stents, i.e., resulting in their growing popularity & demand across both local & regional markets in Japan. Furthermore, continuous advancements in self-expandable stents and their benefits such as feasibility in treating acute myocardial infarction, ability to keep up with artery expansion with a very accurate apposition, and so on, are important factors promoting their demand and driving the Japan coronary stents market.
The report offers the appropriate analysis of the key organizations/companies involved within the Japan coronary stents market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.
List of Key Companies
- Terumo Corporation
- B. Braun Melsungen
- Abbott Laboratories
- Biotronik SE & Co
- GE Healthcare
- Boston Scientific
- Philips Healthcare
- Lepu Medical Technology
- Meril Life Sciences
- MicroPort Scientific
- Sahajanand Medical Technologies
- Translumina Therapeutics
- Vascular Concepts
Key Target Audience
- Market Players
- Government Authorities
- Consulting and Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
In April 2021, Abbott Laboratories, Inc. launched Ultreon 1.0 Software, a coronary imaging platform powered by Artificial Intelligence (AI), in Europe. The software was created primarily to improve the detection of calcium-based blockages and to measure vessel diameter during coronary stenting procedures.
This study forecasts country revenue from 2022 to 2033. Spherical Insights has segmented the Japan coronary stents market based on the below-mentioned segments:
Japan Coronary Stents Market, By Type
- Drug-Eluting Stents
- Bare-Metal Coronary Stents
- Bioabsorbable Stents
Japan Coronary Stents Market, By Deployment
Need help to buy this report?